Compare RDCM & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDCM | FOCL |
|---|---|---|
| Founded | 1985 | N/A |
| Country | Israel | France |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.6M | 203.7M |
| IPO Year | 1999 | 1998 |
| Metric | RDCM | FOCL |
|---|---|---|
| Price | $9.87 | $4.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 134.4K | ★ 199.0K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | $11.50 | N/A |
| Revenue Next Year | $9.74 | N/A |
| P/E Ratio | $16.35 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $9.40 | $4.01 |
| 52 Week High | $16.74 | $6.40 |
| Indicator | RDCM | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 33.20 | 37.55 |
| Support Level | $9.40 | $4.01 |
| Resistance Level | $10.79 | $4.50 |
| Average True Range (ATR) | 0.26 | 0.19 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 20.86 | 58.16 |
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.